abstract |
The invention relates to pharmaceutical compositions of antiviral compounds which may be administered to mammals, in particular to humans suffering from viral infections. These compositions contain particles that are obtained by melt-extruding a mixture containing one or more antiviral compounds and one or more suitable water-soluble polymers, and milling the melt-extruded mixture (extrudate). |